{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:32:05Z","timestamp":1790418725164,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jcv.2015.07.305","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T18:54:57Z","timestamp":1438196097000},"page":"28-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Optimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling"],"prefix":"10.1016","volume":"71","author":[{"given":"Piotr","family":"Kardas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Leboeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2015.07.305_bib0005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/apm.12125","article-title":"The human polyomaviruses: from orphans and mutants to patchwork family","volume":"121","author":"Rinaldo","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.jcv.2015.07.305_bib0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jmv.10450","article-title":"Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40","volume":"71","author":"Knowles","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2015.07.305_bib0015","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of Polyomavirus BK and JC infection and replication in 400 healthy blood donors","volume":"199","author":"Egli","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2015.07.305_bib0020","doi-asserted-by":"crossref","first-page":"e1000363","DOI":"10.1371\/journal.ppat.1000363","article-title":"Seroepidemiology of human polyomaviruses","volume":"5","author":"Kean","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jcv.2015.07.305_bib0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/CVI.00438-12","article-title":"Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus","volume":"20","author":"Nicol","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jcv.2015.07.305_bib0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/apm.12128","article-title":"The human JC polyomavirus (JCPyV): virological background and clinical implications","volume":"121","author":"Hirsch","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.jcv.2015.07.305_bib0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/CMR.05031-11","article-title":"Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-Induced demyelinating disease of the human brain","volume":"25","author":"Ferenczy","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jcv.2015.07.305_bib0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-pathol-020712-164018","article-title":"Progressive multifocal leukoencephalopathy: why gray and white matter","volume":"8","author":"Gheuens","year":"2013","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jcv.2015.07.305_bib0045","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/apm.12134","article-title":"The human polyomavirus BK (BKPyV): virological background and clinical implications","volume":"121","author":"Rinaldo","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.jcv.2015.07.305_bib0050","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1128\/JVI.75.7.3483-3487.2001","article-title":"JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy","volume":"75","author":"Koralnik","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2015.07.305_bib0055","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1128\/JVI.02657-08","article-title":"JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy","volume":"83","author":"Khanna","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2015.07.305_bib0060","doi-asserted-by":"crossref","DOI":"10.1007\/s13365-014-0294-y","article-title":"Immunology of progressive multifocal leukoencephalopathy","author":"Jelcic","year":"2015","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jcv.2015.07.305_bib0065","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/cid\/cir507","article-title":"JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals","volume":"53","author":"Viscidi","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2015.07.305_bib0070","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.jcv.2015.07.305_bib0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1352458511435105","article-title":"Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab","volume":"18","author":"Sorensen","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jcv.2015.07.305_bib0080","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/00007890-199903270-00022","article-title":"Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss","volume":"67","author":"Binet","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2015.07.305_bib0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00007890-199901150-00018","article-title":"Human polyoma virus-associated interstitial nephritis in the allograft kidney","volume":"67","author":"Randhawa","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2015.07.305_bib0090","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","volume":"347","author":"Hirsch","year":"2002","journal-title":"N Engl. J. Med."},{"issue":"Suppl 4","key":"10.1016\/j.jcv.2015.07.305_bib0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/ajt.12110","article-title":"BK polyomavirus in solid organ transplantation","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2015.07.305_bib0100","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1600-6143.2007.01754.x","article-title":"Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients","volume":"7","author":"Binggeli","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2015.07.305_bib0105","series-title":"Humoral and Cellular Immunity to Polyomavirus BK Large T. and VP1 Antigens after Pediatric Kidney Transplantation 2009","first-page":"283","author":"Comoli","year":"2009"},{"key":"10.1016\/j.jcv.2015.07.305_bib0110","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/j.1600-6143.2011.03693.x","article-title":"BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy","volume":"11","author":"Schachtner","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2015.07.305_bib0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-6143.2012.04320.x","article-title":"Replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2015.07.305_bib0120","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.TP.0000061767.32870.72","article-title":"Infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches","volume":"75","author":"Ginevri","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2015.07.305_bib0125","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1600-6143.2005.01000.x","article-title":"Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia","volume":"5","author":"Bohl","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2015.07.305_bib0130","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/TP.0b013e318282ba83","article-title":"Donor and recipient BKV-specific IgG antibody and posttransplantation BKV infection: a prospective single-center study","volume":"95","author":"Sood","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2015.07.305_bib0135","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/CVI.00489-14","article-title":"Inter- and intralaboratory comparison of JC polyomavirus antibody testing using two different virus-like particle-based assays","volume":"21","author":"Kardas","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jcv.2015.07.305_bib0140","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/ajt.12689","article-title":"BK polyomavirus-specific cellular immune responses are age-dependent and strongly correlate with phases of virus replication","volume":"14","author":"Schmidt","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2015.07.305_bib0145","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1093\/brain\/awr206","article-title":"Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome","volume":"134","author":"Aly","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jcv.2015.07.305_bib0150","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/ana.1004","article-title":"Cellular and humoral immune response in progressive multifocal leukoencephalopathy","volume":"49","author":"Weber","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jcv.2015.07.305_bib0155","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.0b013e31823b9b27","article-title":"Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS","volume":"77","author":"Kuhle","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jcv.2015.07.305_bib0160","series-title":"Treatment of P Rogressive Multifocal Leukoencephalopathy with Interleukin 7","first-page":"E1","author":"Alstadhaug","year":"2014"},{"key":"10.1016\/j.jcv.2015.07.305_bib0165","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jcv.2008.06.009","article-title":"BK virus antibody titers and intensity of infections after renal transplantation","volume":"43","author":"Bohl","year":"2008","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2015.07.305_bib0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jcv.2012.09.003","article-title":"BK polyomavirus-associated hemorrhagic cystitis among pediatric allogeneic bone marrow transplant recipients: treatment response and evidence for nosocomial transmission","volume":"56","author":"Koskenvuo","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2015.07.305_bib0175","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcv.2014.11.016","article-title":"Diffuse gastrointestinal bleeding and BK polyomavirus replication in a pediatric allogeneic haematopoietic stem cell transplant patient","volume":"62","author":"Koskenvuo","year":"2015","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2015.07.305_bib0180","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1111\/ajt.12945","article-title":"A case of primary JC polyomavirus infection-associated nephropathy","volume":"14","author":"Lautenschlager","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2015.07.305_bib0185","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1128\/JCM.00030-09","article-title":"Antibody responses to recombinant polyomavirus BK large T. and VP1 proteins in pediatric kidney transplant patients","volume":"47","author":"Bodaghi","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.07.305_bib0190","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1097\/01.ASN.0000023435.07320.81","article-title":"Clinical course of polyoma virus nephropathy in 67 renal transplant patients","volume":"13","author":"Ramos","year":"2002","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138665321500606X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138665321500606X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T11:51:37Z","timestamp":1537444297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138665321500606X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":38,"alternative-id":["S138665321500606X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2015.07.305","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2015.07.305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}